Abstract







 Gorham-Stout disease is a complex disease in which lytic lesions of bone tissue are accompanied by chylothorax and abdominal lymphangioma. The etiology is still unknown. The diagnosis is made by the patient’s clinical and laboratory findings and biopsy results. It may be fatal depending on the organs involved. Although many treatments have been described, successful results have been reported with interferon alpha 2b in recent years. We discuss the clinical diagnosis and treatment of a 5-year-old female patient with osteolytic lesions in the bones after she was referred with chylothorax 

Keywords: Child, Gorham-Stout Syndrome, Interferon Alfa-2b

References

  1. 1. Noda M, Endo C, Hoshikawa Y, et al. Successful management of
  2. intractable chylothorax in Gorham-Stout disease by awake thoracoscopic
  3. surgery. Gen Thorac Cardiovasc Surg. 2013;61(6):356-
  4. 8.
  5. 2. De Smet K, De Maeseneer M, Huijssen-Huisman E, Van Gorp
  6. V, Hachimi-Idrissi S, Ernst C. A rare cause of dyspnea due to
  7. chylothorax. Emerg Radiol 2010;17:503-5.
  8. 3. Kuriyama DK, McElligott SC, Glaser DW, Thompson KS. Treatment
  9. of Gorham-Stout disease with zoledronic acid and interferon-α:
  10. A case report and literature review. J Pediatr Hematol Oncol
  11. 2010;32:579-584.
  12. 4. Brodszki N, Länsberg J-K, Dictor M, et al. A novel treatment
  13. approach for paediatric Gorham–Stout syndrome with chylothorax.
  14. Acta Paediatr 2011;100:1448-53.
  15. 5. Deveci M, Inan N, Çorapçioǧlu F, Ekingen G. Gorham-Stout
  16. syndrome with chylothorax in a six-year-old boy. Indian J Pediatr.
  17. 2011;78:737-9.
  18. 6. Brodszki N, Länsberg JK, Dictor M, et al. A novel treatment
  19. approach for paediatric Gorham-Stout syndrome with chylothorax.
  20. Acta Paediatr Int J Paediatr 2011;100:1448-53.
  21. 7. Nozawa A, Ozeki M, Kuze B, Asano T, Matsuoka K, Fukao
  22. T. Gorham-Stout disease of the skull base with hearing loss:
  23. Dramatic recovery and antiangiogenic therapy. Pediatr Blood
  24. Cancer 2016;63:931-4.
  25. 8. Gorham Lw, Stout AP. Massive osteolysis (acute spontaneous
  26. absorption of bone, phantom bone, disappearing bone); its relation
  27. to hemangiomatosis. J Bone Joint Surg Am 1955;37-A(5):985-
  28. 1004.
  29. 9. Patel DV. Gorham’s disease or massive osteolysis. Clin Med Res
  30. 2005;3:65-74.
  31. 10. Kakhaki AD, Khodadad K, Pejhan S, Karimi S, Arab M, Saghebi R,
  32. et al. Gorham’s Disease with chest wall involvement: A case report
  33. and a review of the literature. Iran Red Crescent Med J 2014;16.
  34. e12180.
  35. 11. Kose M, Pekcan S, Dogru D, Akyuz C, Ozcelik U, Ozsurekci Y, et al.
  36. Gorham-Stout syndrome with chylothorax: Successful remission
  37. by interferon alpha-2b. Pediatr Pulmonol 2009;44:613-5.
  38. 12. Trenor CC, Chaudry G. Complex lymphatic anomalies. Semin
  39. Pediatr Surg 2014;23:186-90.
  40. 13. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon Alfa-2a
  41. therapy for life-threatening hemangiomas of infancy. N Engl J Med
  42. 1992;326:1456-63.
  43. 14. Takahashi A, Ogawa C, Kanazawa T, Watanabe H, Suzuki M,
  44. Suzuki N, et al. Remission induced by interferon alfa in a patient
  45. with massive osteolysis and extension of lymph-hemangiomatosis:
  46. A severe case of Gorham-Stout syndrome. J Pediatr Surg
  47. 2005;40:E47-E50.
  48. 15. Timke C, Krause MF, Oppermann H, Leuschner I, Claviez
  49. A. Interferon alpha 2b treatment in an eleven-year-old boy
  50. with disseminated lymphangiomatosis. Pediatr Blood Cancer
  51. 2007;48:108-11.
  52. 16. Hagberg H, Lamberg K, Aström G. Alpha-2b interferon and oral
  53. clodronate for Gorham’s disease. Lancet 1997;350:1822-3.
  54. 17. Grunewald TGP, Damke L, Maschan M, Petrova U, Surianinova O,
  55. Esipenko A, et al. First report of effective and feasible treatment of
  56. multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in
  57. a child. Ann Oncol 2010;21:1733-4.

How to cite

1.
Aydın E. A Rare Cause of Chylothorax in Children: Gorham-Stout Syndrome. Turk J Pediatr Dis [Internet]. 2019 Mar. 21 [cited 2025 May 25];13(1):36-9. Available from: https://turkjpediatrdis.org/article/view/638